Medicis Pharmaceutical Corp. (MRX) Tops Q4 EPS by 15c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/23/2026
- Wall St falls as tech earnings spark AI spending worries and oil hits $100
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Google increases capex forecast again after cloud-driven quarterly beat
- As Musk pivots beyond cars, Tesla’s autos engine is under strain
- RTX stock jumps as company lifts guidance after Q2 beat
Marex Group PLC (MRX) PT Raised to $42 at Jefferies
March 10, 2025 4:52 AM EDTJefferies analyst Daniel Fannon raised the price target on Marex Group PLC (NASDAQ: MRX) to $42.00 (from $38.00) while maintaining a Buy rating.
The analyst comments "Following 4Q24 results, our EPS estimate for 1Q25 remains unchanged at $0.83 and our FY25 EPS estimate increases from $3.00 to $3.11. These... More
